Peptidoglycan Recognition Protein 3 Does Not Alter the Outcome of Pneumococcal Pneumonia in Mice

Pneumococci frequently cause community-acquired pneumonia, a disease with high mortality rates, particularly in young children and in the elderly. Endogenous antimicrobial peptides and proteins such as PGLYRP3 may contribute to the progression and outcome of this disease. Since increasing antibiotic...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in microbiology 2018-02, Vol.9, p.103-103
Main Authors: Shrivastav, Anshu, Dabrowski, Alexander N, Conrad, Claudia, Baal, Nelli, Hackstein, Holger, Plog, Stephanie, Dietert, Kristina, Gruber, Achim D, N'Guessan, Philippe D, Aly, Sahar, Suttorp, Norbert, Zahlten, Janine
Format: Article
Language:English
Subjects:
innate immunity
Microbiology
peptidoglycan recognition proteins
PGLYRP
PGRP
pneumococcal pneumonia
Streptococcus pneumoniae
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pneumococci frequently cause community-acquired pneumonia, a disease with high mortality rates, particularly in young children and in the elderly. Endogenous antimicrobial peptides and proteins such as PGLYRP3 may contribute to the progression and outcome of this disease. Since increasing antibiotic resistant strains occur all over the world, these endogenous antimicrobial molecules are interesting new targets for future therapies. In this study, the expression pattern of PGLYRP3 was analyzed in alveolar epithelial cells, alveolar macrophages and neutrophils. Additionally, the function of PGLYRP3 during -induced pneumonia was investigated in a murine pneumococcal pneumonia model using PGLYRP3KO mice. PGLYRP3 is expressed in all selected cell types but pneumococcus-dependent induction of PGLYRP3 was observed only in neutrophils and alveolar macrophages. Interestingly, there were no significant differences in the bacterial loads within the lungs, the blood or the spleens, in the cytokine response, the composition of immune cells and the histopathology between wild type and PGLYRP3KO mice. Finally, we could neither observe significant differences in the clinical symptoms nor in the overall survival. Collectively, PGLYRP3 seems to be dispensable for the antibacterial defense during pneumococcal pneumonia.
ISSN:1664-302X
1664-302X
DOI:10.3389/fmicb.2018.00103